Obeticholic acid (OCA), an effective Farnesoid X receptor (FXR) agonist which is derived from chenodeoxycholic acid, improves NAFLD/NASH by regulating bile acid synthesis and enterohepatic circulation in the body (Mudaliar et al., 2013). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.